Ambu A/S (LON:0MJF)

Market Cap	2.75B
Revenue (ttm)	705.55M
Net Income (ttm)	71.17M
Shares Out	n/a
EPS (ttm)	0.27
PE Ratio	38.67
Forward PE	35.16
Dividend	0.05 (0.05%)
Ex-Dividend Date	Dec 4, 2025

Volume	91,802
Average Volume	28,912
Open	88.10
Previous Close	88.00
Day's Range	87.65 - 88.30
52-Week Range	80.13 - 143.85
Beta	1.55
RSI	52.97
Earnings Date	Feb 4, 2026

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also prov...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,384
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0MJF

Financial Performance

In 2025, Ambu A/S's revenue was 6.04 billion, an increase of 11.98% compared to the previous year's 5.39 billion. Earnings were 609.00 million, an increase of 159.15%.

Financial numbers in DKK